Curious about Bristol Myers (BMY) Q1 Performance? Explore Wall Street Estimates for Key MetricsZacks Investment Research • 04/18/25
One Sector Paying Big Dividends Is Off to the Best Start in 25 Years Despite Tariffs24/7 Wall Street • 04/18/25
U.S. Food and Drug Administration Updates CAMZYOS® (mavacamten) Label to Reduce Echocardiography Monitoring Requirements and ContraindicationsBusiness Wire • 04/18/25
Bristol Myers Squibb (BMY) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research • 04/17/25
2SEVENTY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 2seventy bio, Inc. - TSVTBusiness Wire • 04/16/25
Gilead vs Bristol Myers: Which Biotech Bigwig is a Better Bet Now?Zacks Investment Research • 04/16/25
Bristol Myers Slumps On Heart Drug Failure — Taking Cytokinetics With ItInvestors Business Daily • 04/14/25
These Large-Cap Stocks With China And EU Exposure Got Crushed In The One Of The Most Volatile Trading Week (Apr 7-Apr 11): Are These In Your Portfolio?Benzinga • 04/13/25
U.S. Food and Drug Administration Approves Opdivo® (nivolumab) plus Yervoy® (ipilimumab) as a First-Line Treatment for Unresectable or Metastatic Hepatocellular CarcinomaBusiness Wire • 04/11/25
Need Dependable Passive Income? 4 Safe Stocks Paying 4%-10% Dividends Are Tariff Discount Priced24/7 Wall Street • 04/10/25
Autos, pharma, luxury and more: The global sectors soaring after Trump's tariffs walkbackCNBC • 04/10/25
Here's Why Bristol Myers Squibb (BMY) Gained But Lagged the Market TodayZacks Investment Research • 04/09/25
Trump's Tariffs Circle Pharma Industry: Who It Affects And How It May Play OutSeeking Alpha • 04/09/25